Clinical

Dataset Information

0

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining oxaliplatin with capecitabine in treating patients who have colorectal, appendix, or small bowel cancer.

DISEASE(S): Colorectal Cancer,Small Intestine Cancer,Intestinal Neoplasms,Carcinoma Of The Appendix

PROVIDER: 2006418 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Genomics Appendix metagenome
| PRJNA596776 | ENA
Clinical Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
| 2003528 | ecrin-mdr-crc
Clinical Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
| 2003602 | ecrin-mdr-crc
Clinical Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
| 2006400 | ecrin-mdr-crc
Clinical Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2006173 | ecrin-mdr-crc
Clinical Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan
| 2006224 | ecrin-mdr-crc
Clinical Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer
| 2004153 | ecrin-mdr-crc
Genomics Human Appendix
| PRJNA414153 | ENA
Clinical ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
| 2006171 | ecrin-mdr-crc
Clinical Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2004017 | ecrin-mdr-crc